ArticleVaccine2023

Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older.

Esther Saiag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.